Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche.

Li, Yinghui; He, Mei; Zhang, Wenshan; Liu, Wei; Xu, Hui; Yang, Ming; Zhang, Hexiao; Liang, Haiwei et al. · Nat Commun · 2023

basic_science · Level V

Where this comes from

Abstract

Limited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34<sup>+</sup>CD38<sup>-</sup>CD45RA-CD90<sup>+</sup>CD49f <sup>low</sup>CD62L<sup>-</sup>CD133<sup>+</sup> subpopulation. Specifically, the expansion of megakaryocyte-biased HSCs is supported by a biomimetic niche-like microenvironment, which generates a suitable cytokine milieu and supplies the appropriate physical scaffolding. Thus, beyond clarifying the existence and immuno-phenotype of human megakaryocyte-biased HSC, our study demonstrates a flexible human HSC expansion strategy that could help realize the strong clinical promise of HSC-based therapies.

Medical subject headings